Reynolds, GP, Zhang, ZJ, Zhang, XB. Association of antipsychotic drug-induced weight
gain with a 5-HT2C receptor gene polymorphism.
2002; 359: 2086–7.
Templeman, LA, Reynolds, GP, Arranz, B, San, L. Polymorphisms of the 5-HT2C receptor and leptin
genes are associated with antipsychotic drug-induced weight gain in
Caucasian subjects with a first-episode psychosis.
Ellingrod, VL, Perry, PJ, Ringold, JC, Lund, BC, Bever-Stille, K, Fleming, F, Holman, TL, Miller, D. Weight gain associated with the −759C/T polymorphism
of the 5HT2C receptor and olanzapine. Am J Med
Genet B NeuroPsychiatr Genet
2005; 134: 76–8.
Miller, DD, Ellingrod, VL, Holman, TL, Buckley, PF, Arndt, S. Clozapine-induced weight gain associated with the
5HT2C receptor −759C/T polymorphism. Am J Med
Genet B NeuroPsychiatr Genet
Reynolds, GP. Receptor mechanisms in the treatment of
schizophrenia. J Psychopharmacol
2004; 18: 340–5.
American Psychiatric Association. Diagnostic and
Statistical Manual of Mental Disorders (4th
Heiskanen, T, Niskanen, L, Lyytikainen, R, Saarinen, PI, Hintikka, J. Metabolic syndrome in patients with
schizophrenia. J Clin Psychiatry
2003; 64: 575–9.
De Hert, MA, van Winkel, R, Van Eyck, D, Hanssens, L, Wampers, M, Scheen, A, Peuskens, J. Prevalence of the metabolic syndrome in patients
with schizophrenia treated with antipsychotic medication.
Allison, DB, Mentore, JL, Heo, M, Chandler, LP, Capelleri, JC, Infante, MC, Weiden, PJ. Antipsychotic-induced weight gain: a comprehensive
research synthesis. Am J Psychiatry
1999; 156: 1686–96.
Wu, RR, Zhao, JP, Liu, ZN, Zhai, JG, Guo, XF, Guo, WB, Tang, JS. Effects of typical and atypica antipsychotics on
glucose-insu in homeostasis and ipid metabolism in first-episode
2006; 186: 572–8.
Osborn, DP, Levy, G, Nazareth, I, Petersen, I, Islam, A, King, MB. Relative risk of cardiovascular and cancer mortality
in people with severe mental illness from the United Kingdom's General
Practice Research Database. Arch Gen
2007; 64: 242–9.
Wannamethee, SG, Shaper, AG, Perry, IJ. Smoking as a modifiable risk factor for type 2
diabetes in middle-aged men. Diabetes
2001; 24: 1590–5.
Yuan, X, Yamada, K, Ishiyama-Shigemoto, S, Koyama, W, Nonaka, K. Identification of polymorphic loci in the promoter
region of the serotonin 5-HT2C receptor gene and their association with
obesity and type II diabetes.
2000; 43: 373–6.
Hoffstedt, J, Eriksson, P, Mottagui-Tabar, S, Arner, P. A polymorphism in the leptin promoter region (-2548
G/A) influences gene expression and adipose tissue secretion of
leptin. Horm Metab Res
2002; 34: 355–9.
Mammes, O, Betoulle, D, Aubert, R, Herbeth, B, Siest, G, Fumeron, F. Association of the G-2548A polymorphism in the 5′
region of the LEP gene with overweight. Ann Hum
2000; 64: 391–4.
Wang, TN, Huang, MC, Chang, WT, Ko, AM, Tsai, EM, Liu, CS, Lee, CH, Ko, YC. G-2548A polymorphism of the leptin gene is
correlated with extreme obesity in Taiwanese aborigines.
Obesity (Silver Spring)
2006; 14: 183–7.
Franks, PW, Brage, S, Luan, J, Ekelund, U, Rahman, M, Farooqi, IS, Halsall, I, O'Rahilly, S, Wareham, NJ. Leptin predicts a worsening of the features of the
metabolic syndrome independently of obesity. Obes
2005; 13: 1476–84.
Finn, PD, Cunningham, MJ, Rickard, DG, Clifton, DK, Steiner, RA. Serotonergic neurons are targets for leptin in the
monkey. J Clin Endocrinol Metab
2001; 86: 422–6.
Hay-Schmidt, A, Helboe, L, Larsen, PJ. Leptin receptor immunoreactivity is present in
ascending serotonergic and catecholaminergic neurons of the
2001; 73: 215–26.
Von Meyenburg, C, Langhans, W, Hrupka, BJ. Evidence for a role of the 5-HT2C receptor in
central lipopolysaccharide-, interleukin-1 beta-, and leptin-induced
anorexia. Pharmacol Biochem Behav
2003; 74: 1025–31.